CAPR

Capricor Therapeutics Inc

• Simply Wall St·12h ago

  Capricor Therapeutics (CAPR) Is Down 5.8% After FDA Adcom Set, Russell Exit News - Has The Bull Case Changed?

• TipRanks·20h ago

  Capricor Therapeutics (CAPR) Gets a Buy from Cantor Fitzgerald

• Simply Wall St·2d ago

  Capricor Therapeutics (CAPR) Stock Looks Overvalued As Its 442% Run Draws Focus

• Simply Wall St·5d ago

  Capricor Therapeutics (CAPR) Could Be 58% Undervalued Following FDA Focus And Index Removal

• Seeking Alpha·6d ago

  Four stock-moving events to watch as FDA revives AdComs

• NASDAQ·06/29 08:26

  Capricor Advances For FDA Advisory Committee Meeting In July Amid Strong Long-Term Deramiocel Data

• Simply Wall St·06/27 23:13

  Capricor Therapeutics (CAPR) Is Down 6.8% After Positive Five-Year HOPE-2 DMD Data And FDA Update

• TipRanks·06/26 21:53

  Capricor Faces FDA Advisory Review for DMD Therapy

• NASDAQ·06/26 19:27

  Notable Friday Option Activity: HIMS, QSR, CAPR

• Benzinga·06/26 18:06

  What's Going On With Capricor Therapeutics Stock On Friday?

• TipRanks·06/26 16:40

  Analysts’ Top Healthcare Picks: Strata Critical Medical (SRTA), Butterfly Network (BFLY)

• TipRanks·06/26 16:06

  Midday Fly By: On Semi to acquire Synaptics, OpenAI leans toward 2027 IPO

• NASDAQ·06/26 15:06

  FDA Advisory Panel To Review Capricor's Deramiocel BLA In DMD

• Reuters·06/26 15:02

  BUZZ-Capricor tumbles as FDA panel meet for Duchenne cell therapy adds risk worries

• PUBT·06/26 14:10

  Capricor Therapeutics to face FDA advisory panel review of deramiocel BLA in Duchenne muscular dystrophy